365 related articles for article (PubMed ID: 7035555)
1. Modulation of granulomatous hypersensitivity. IV. Immunoglobulin and antibody production by vigorous and immunomodulated liver granulomas of Schistosoma mansoni-infected mice.
Boros DL; Amsden AF; Hood AT
J Immunol; 1982 Mar; 128(3):1050-3. PubMed ID: 7035555
[TBL] [Abstract][Full Text] [Related]
2. Tumoricidal macrophages isolated from liver granulomas of Schistosoma mansoni-infected mice.
Loveless SE; Wellhausen SR; Boros DL; Heppner GH
J Immunol; 1982 Jan; 128(1):284-8. PubMed ID: 7054278
[TBL] [Abstract][Full Text] [Related]
3. Schistosome egg antigen(s) presentation and regulatory activity by macrophages isolated from vigorous or immunomodulated liver granulomas of Schistosoma mansoni-infected mice.
Elliott DE; Boros DL
J Immunol; 1984 Mar; 132(3):1506-10. PubMed ID: 6319495
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation.
Joseph AL; Boros DL
J Immunol; 1993 Nov; 151(10):5461-71. PubMed ID: 8228238
[TBL] [Abstract][Full Text] [Related]
5. Modulation of granulomatous hypersensitivity. VI. T lymphocyte subsets influence mast cell density in liver granulomas of Schistosoma mansoni-infected mice.
Weinstock JV; Boros DL
J Immunol; 1983 Aug; 131(2):959-61. PubMed ID: 6602849
[TBL] [Abstract][Full Text] [Related]
6. Modulation of granulomatous hypersensitivity. I. Characterization of T lymphocytes involved in the adoptive suppression of granuloma formation in Schistosoma mansoni-infected mice.
Chensue SW; Boros DL
J Immunol; 1979 Sep; 123(3):1409-14. PubMed ID: 313956
[TBL] [Abstract][Full Text] [Related]
7. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. I. Analysis of antibody responses.
Correa-Oliveira R; Sher A; James SL
J Immunol; 1984 Sep; 133(3):1581-6. PubMed ID: 6747298
[TBL] [Abstract][Full Text] [Related]
8. Modulation of granulomatous hypersensitivity. II. Participation of Ly 1+ and Ly 2+ T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni-infected mice.
Chensue SW; Wellhausen SR; Boros DL
J Immunol; 1981 Jul; 127(1):363-7. PubMed ID: 6972410
[TBL] [Abstract][Full Text] [Related]
9. Production of the lymphokine soluble immune response suppressor (SIRS) during chronic experimental schistosomiasis mansoni.
Aune TM; Freeman GL; Colley DG
J Immunol; 1985 Oct; 135(4):2768-71. PubMed ID: 4031499
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of splenic auto-anti-idiotypic plaque-forming cells in mice infected with Schistosoma mansoni.
Powell MR; Colley DG
J Immunol; 1985 Jun; 134(6):4140-5. PubMed ID: 3886797
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Schistosoma mansoni egg-induced granuloma formation. III. Evidence for an anti-idiotypic, I-J-positive, I-J-restricted, soluble T suppressor factor.
Abe T; Colley DG
J Immunol; 1984 Apr; 132(4):2084-8. PubMed ID: 6199422
[TBL] [Abstract][Full Text] [Related]
12. Substance P and somatostatin can modulate the amount of IgG2a secreted in response to schistosome egg antigens in murine schistosomiasis mansoni.
Blum AM; Metwali A; Mathew RC; Elliott D; Weinstock JV
J Immunol; 1993 Dec; 151(12):6994-7004. PubMed ID: 7505019
[TBL] [Abstract][Full Text] [Related]
13. Evolving T cell responses in murine schistosomiasis. Th2 cells mediate secondary granulomatous hypersensitivity and are regulated by CD8+ T cells in vivo.
Chensue SW; Warmington KS; Hershey SD; Terebuh PD; Othman M; Kunkel SL
J Immunol; 1993 Aug; 151(3):1391-400. PubMed ID: 8335935
[TBL] [Abstract][Full Text] [Related]
14. Production of angiotensin I converting enzyme by liver granuloma macrophages of Schistosoma mansoni infected mice.
Weinstock JV; Boros DL
Gastroenterology; 1982 Jan; 82(1):106-10. PubMed ID: 6273251
[TBL] [Abstract][Full Text] [Related]
15. Induction of granuloma modulation in murine schistosomiasis mansoni by enteric exposure to schistosome eggs.
Weinstock JV; Blum AM; Kassab JT
J Immunol; 1985 Jul; 135(1):560-3. PubMed ID: 3998473
[TBL] [Abstract][Full Text] [Related]
16. Characterization of granuloma T lymphocyte function from Schistosoma mansoni-infected mice.
Ragheb S; Boros DL
J Immunol; 1989 May; 142(9):3239-46. PubMed ID: 2523427
[TBL] [Abstract][Full Text] [Related]
17. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile.
Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Ward JM; Cheever AW; Paul WE; Sher A
J Immunol; 1999 Jul; 163(1):337-42. PubMed ID: 10384133
[TBL] [Abstract][Full Text] [Related]
18. Delayed hypersensitivity granuloma formation around Schistosoma mansoni eggs in vitro. III. Granuloma formation and modulation in human Schistosomiasis mansoni.
Doughty BL; Ottesen EA; Nash TE; Phillips SM
J Immunol; 1984 Aug; 133(2):993-7. PubMed ID: 6234365
[TBL] [Abstract][Full Text] [Related]
19. Characterization of regulatory (interferon-alpha/beta) and accessory (LAF/IL 1) monokine activities from liver granuloma macrophages of Schistosoma mansoni-infected mice.
Elliott DE; Righthand VF; Boros DL
J Immunol; 1987 Apr; 138(8):2653-62. PubMed ID: 3104471
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Schistosoma mansoni antigen-reactive T cell clones that form granulomas in vitro.
Lammie PJ; Linette GP; Phillips SM
J Immunol; 1985 Jun; 134(6):4170-5. PubMed ID: 3886799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
